(Q34392552)

English

Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques (English)

1 reference

Europe PubMed Central

1 August 2017

0 references

author name string

Wael A Aljaroudi

1

1 reference

Europe PubMed Central

1 August 2017

Milind Y Desai

2

1 reference

Europe PubMed Central

1 August 2017

W H Wilson Tang

3

1 reference

Europe PubMed Central

1 August 2017

Dermot Phelan

4

1 reference

Europe PubMed Central

1 August 2017

Manuel D Cerqueira

5

1 reference

Europe PubMed Central

1 August 2017

Wael A Jaber

6

1 reference

Europe PubMed Central

1 August 2017

publication date

1 April 2014

1 reference

Europe PubMed Central

1 August 2017

Journal of Nuclear Cardiology

1 reference

Europe PubMed Central

1 August 2017

21

1 reference

Europe PubMed Central

1 August 2017

2

1 reference

Europe PubMed Central

1 August 2017

271-283

1 reference

Europe PubMed Central

1 August 2017

https://scigraph.springernature.com/pub.10.1007/s12350-013-9800-5

0 references

Transthyretin-related amyloidoses and the heart: a clinical overview

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Cardiac transthyretin amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Safety and efficacy of RNAi therapy for transthyretin amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

The premortem recognition of systemic senile amyloidosis with cardiac involvement

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

How to diagnose cardiac amyloidosis early: impact of ECG, tissue Doppler echocardiography, and myocardial biopsy.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Prognostic value of fragmented QRS in cardiac AL amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohor

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Prognostic significance of strain Doppler imaging in light-chain amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Cardiovascular magnetic resonance in cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Quantification of extracellular matrix expansion by CMR in infiltrative heart disease

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Nuclear imaging in cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

The hereditary amyloidoses

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Molecular imaging of amyloidosis: will the heart be the next target after the brain?

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Novel method for quantitative evaluation of cardiac amyloidosis using (201)TlCl and (99m)Tc-PYP SPECT.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Cardiac positron-emission tomography images with an amyloid-specific tracer in familial transthyretin-related systemic amyloidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Value of Electrocardiogram in the Differentiation of Hypertensive Heart Disease, Hypertrophic Cardiomyopathy, Aortic Stenosis, Amyloidosis, and Fabry Disease

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Prognosis Assessment of Cardiac Involvement in Systemic AL Amyloidosis by Magnetic Resonance Imaging

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9800-5

21 January 2018

Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal Myocardial Function Assessed by Tissue Velocity, Strain, and Strain Rate Tissue Doppler Echocardiography in Patients With AL (Primary) Cardiac Amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical use of differential nuclear medicine modalities in patients with ATTR amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnetic resonance imaging in cardiac amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of Impaired Left Ventricular Systolic Function by Doppler Myocardial Imaging in Patients With Systemic Amyloidosis and No Evidence of Cardiac Involvement by Standard Two-Dimensional and Doppler Echocardiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of serum amyloid P-component (SAP) by amyloid fibrils

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic and therapeutic approach of systemic amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24347127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12350-013-9800-5

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34392552&oldid=1980920286"